Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
Por um escritor misterioso
Descrição
Baricitinib Versus Tocilizumab for the Treatment of Moderate to
The signal pathways and treatment of cytokine storm in COVID-19
Drug repurposing approach to fight COVID-19
Tocilizumab treatment for COVID-19 patients: a systematic review
The signal pathways and treatment of cytokine storm in COVID-19
Two Years into the COVID-19 Pandemic: Lessons Learned
JCM, Free Full-Text
Frontiers Tocilizumab and COVID-19: Timing of Administration and
Use of Baricitinib in Treatment of COVID-19: A Systematic Review
Experience With the Use of Baricitinib and Tocilizumab Monotherapy
Subcutaneous tocilizumab treatment in patients with severe COVID
Repurposing clinically available drugs and therapies for
Triple immune modulator therapy for aberrant hyperinflammatory
JAK inhibition as a new treatment strategy for patients with COVID
de
por adulto (o preço varia de acordo com o tamanho do grupo)
